Stay updated on UBX1325 Safety in Macular Disease Clinical Trial

Sign up to get notified when there's something new on the UBX1325 Safety in Macular Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the UBX1325 Safety in Macular Disease Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision: v3.4.3 is a minor version update replacing v3.4.2. The page’s content and functionality related to the study details remain unchanged.
    Difference
    0.1%
    Check dated 2026-03-12T21:09:24.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Revision: v3.4.2 replaces v3.4.1 on the page. No study content or critical sections appear to be changed; to avoid alerting for small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T01:53:42.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    UI revision from v3.4.0 to v3.4.1 was applied and does not modify any study details or page content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T23:30:17.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Show glossary toggle was added and several metadata labels were updated: 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and Revision to v3.4.0, replacing the previous 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and Revision: v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-28T19:50:44.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The site template updated from v3.3.3 to v3.3.4; no study details or user-facing content were changed.
    Difference
    0.1%
    Check dated 2026-01-14T03:52:38.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added a dedicated Locations section listing California, Florida, Indiana, and Texas as study sites, and removed the individual state location sections for these states. Updated the page revision from v3.3.2 to v3.3.3 and removed the HHS Vulnerability Disclosure footer link.
    Difference
    0.6%
    Check dated 2025-12-23T20:38:58.000Z thumbnail image

Stay in the know with updates to UBX1325 Safety in Macular Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the UBX1325 Safety in Macular Disease Clinical Trial page.